Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1500 participants
OBSERVATIONAL
2019-12-06
2022-11-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer
NCT06775470
Search for Predictors of Therapeutic Response in Ovarian Carcinoma
NCT01391351
Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy
NCT06588322
Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation
NCT05763472
Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma
NCT03302884
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with ovarian and/or primitive peritoneal and/or fallopian tubes carcinoma, histologically confirmed, with an advanced stage at diagnosis (stage III to IV FIGO 2014)
* Patient in first line therapy
* Available tumor sample fixed in formalin and included in paraffin (FFPE):
* in pre-chemotherapy, insofar as possible
* having a sufficient tumor surface, with a final cellularity of at least 20%
* Identification of a molecular genetics' cancer platform participant in GREAT and an onco-geneticists team working with the investigator team
* Patient consenting her data to be collected and submitted through an automated processing
* Patient beneficiary from the French social security
Exclusion Criteria
* Patient pregnant or breastfeeding
* Patient under legal protection (guardianship or court order) or unable to consent
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
ARCAGY/ GINECO GROUP
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thibault De La Motte Rouge, MD.
Role: PRINCIPAL_INVESTIGATOR
Centre Eugène Marquis, Rennes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de Radiothérapie et d'Oncologie de Moyenne Garonne (CROMG)
Agen, , France
Hôpital Privé d'Aix en Provence
Aix-en-Provence, , France
Centre Hospitalier Général d'Aix-en-Provence
Aix-en-Provence, , France
CHU Amiens
Amiens, , France
Clinique Victor PAUCHET
Amiens, , France
Institut de Cancérologie de l'Ouest - ICO
Angers, , France
Hôpital Privé d'Antony - Ramsay Santé
Antony, , France
CH Arras
Arras, , France
CH Auxerre
Auxerre, , France
Institut Sainte Catherine
Avignon, , France
Clinique Belharra
Bayonne, , France
CH Côte Basque
Bayonne, , France
Centre Hospitalier de Beauvais
Beauvais, , France
CHRU Jean Minjoz
Besançon, , France
Reims Icone
Bezannes, , France
CH de Blois
Blois, , France
Hôpital Avicenne
Bobigny, , France
CHU de Bordeaux - Hôpital Pellegrin
Bordeaux, , France
Clinique Tivoli
Bordeaux, , France
Institut Bergonié
Bordeaux, , France
Polyclinique Bordeaux Nord
Bordeaux, , France
Centre Hospitalier Fleyriat - BOURG-EN-BRESSE
Bourg-en-Bresse, , France
CHU Brest
Brest, , France
Hôpital Femme Mère Enfant
Bron, , France
Centre François Baclesse
Caen, , France
Centre Maurice Tubiana
Caen, , France
CH de Cahors
Cahors, , France
CH Carcassonne
Carcassonne, , France
Hôpital Général de Castres
Castres, , France
Medipole de Savoie
Challes-les-Eaux, , France
CH Chalon sur Saone
Chalon-sur-Saône, , France
CH Metropole Savoie
Chambéry, , France
Centre d'Oncologie et de Radiothérapie 37
Chambray-lès-Tours, , France
Centre Hospitalier de Chateauroux
Châteauroux, , France
CHPC - Hôpital Louis Pasteur
Cherbourg, , France
CH Cholet
Cholet, , France
Hôpital Antoine Béclère
Clamart, , France
Centre Jean Perrin
Clermont-Ferrand, , France
CH Alpes Léman
Contamine-sur-Arve, , France
Centre Hospitalier Sud Francilien (Site Gilles de Corbeil)
Corbeil-Essonnes, , France
Clinique des Cèdres
Cornebarrieu, , France
Clinique de Flandre
Coudekerque-Branche, , France
Groupe Hospitalier public du Sud de l'Oise (GHPSO)
Creil, , France
CHI Creteil
Créteil, , France
Centre Georges François Leclerc
Dijon, , France
CHU Dijon
Dijon, , France
Institut de Cancérologie de Bourgogne - GRReCC
Dijon, , France
Clinique du Mousseau (CMCO) - Ramsay Santé
Évry, , France
Centre Hospitalier Intercommunal de Fréjus Saint Raphael
Fréjus, , France
GH Mutualiste de Grenoble
Grenoble, , France
Hôpital Privé Drôme Ardèche - Clinique Pasteur
Guilherand-Granges, , France
Centre Hospitalier Marne-la-Vallée
Jossigny, , France
Centre Hospitalier Départemental de Vendée
La Roche-sur-Yon, , France
CHU Grenoble Alpes - Site Nord (La Tronche)
La Tronche, , France
Hôpital André Mignot
Le Chesnay, , France
Les Hôpitaux de Chartres
Le Coudray, , France
Hôpital Privé de l'Estuaire
Le Havre, , France
CHU Bicêtre
Le Kremlin-Bicêtre, , France
Centre Hospitalier du Mans
Le Mans, , France
CH de Lens
Lens, , France
Institut Hospitalier Franco-Britannique
Levallois-Perret, , France
Polyclinique de Limoges - Clinique Chenieux
Limoges, , France
CHU de Limoges - Hôpital Dupuytren
Limoges, , France
Groupe Hospitalier Bretagne Sud - Hôpital du Scorff
Lorient, , France
HCL - Hôpital de la Croix Rousse
Lyon, , France
Clinique de l'infirmerie Protestante
Lyon, , France
Centre Léon Bérard
Lyon, , France
Clinique de la Sauvegarde
Lyon, , France
Hôpital Privé Jean Mermoz
Lyon, , France
APHM - Hôpital de la Timone
Marseille, , France
Hôpital Nord
Marseille, , France
Institut Paoli Calmettes
Marseille, , France
Centre Hospitalier Layné
Mont-de-Marsan, , France
Hôpital Nord Franche Comté
Montbéliard, , France
CH de Montelimar
Montélimar, , France
Centre de Cancérologe du Grand Montpellier
Montpellier, , France
CHRU de Montpellier - Hôpital Saint-Eloi
Montpellier, , France
ICM - Val d'Aurelle
Montpellier, , France
Centre Azuréen de Cancérologie
Mougins, , France
Oracle - Centre d'Oncologie de Gentilly
Nancy, , France
Hôpital Privé du Confluent
Nantes, , France
Clinique Hartmann
Neuilly-sur-Seine, , France
Centre Antoine Lacassagne
Nice, , France
Institut de Cancérologie du Gard - ONCOGARD
Nîmes, , France
Institut de Cancérologie du Gard
Nîmes, , France
CHR Orléans
Orléans, , France
Hôpital de la Pitié Salpétrière
Paris, , France
GH Saint Joseph
Paris, , France
Groupe Hospitalier Diaconesses - Croix Saint-Simon
Paris, , France
HEGP
Paris, , France
Hôpital Bichat
Paris, , France
Hôpital Cochin
Paris, , France
Hôpital Lariboisière
Paris, , France
Institut Curie
Paris, , France
Institut Mutualiste Montsouris
Paris, , France
CH Pau
Pau, , France
Centre Catalan d'Oncologie
Perpignan, , France
CH Perpignan
Perpignan, , France
Clinique Francheville
Périgueux, , France
HCL - Centre Hospitalier Lyon Sud
Pierre-Bénite, , France
Centre CARIO-HPCA
Plérin, , France
Hôpital de la Milétrie
Poitiers, , France
CH René Dubos
Pontoise, , France
CH Annecy Genevois
Pringy, , France
Clinique de la Croix du Sud
Quint-Fonsegrives, , France
Centre Eugène Marquis
Rennes, , France
Hôpitaux Drôme Nord - Centre Hospitalier Romans
Romans-sur-Isère, , France
Centre Henri Becquerel
Rouen, , France
Clinique Mathilde
Rouen, , France
Centre Frédéric Joliot
Rouen, , France
Centre Hospitalier Yves Le Foll
Saint-Brieuc, , France
Institut Curie - Site Saint Cloud
Saint-Cloud, , France
Hôpital Privé de La Loire Saint-Etienne
Saint-Etienne, , France
Centre Hospitalier Privé Saint Grégoire
Saint-Grégoire, , France
Institut de Cancérologie de l'Ouest - ICO
Saint-Herblain, , France
HIA Begin
Saint-Mandé, , France
Clinique Mutualiste de l'Estuaire
Saint-Nazaire, , France
CHU Saint-Etienne - Pôle de Cancérologie
Saint-Priest-en-Jarez, , France
Centre Médicale Sainte Feyre Alfred Leune
Sainte-Feyre, , France
Clinique Charcot
Sainte-Foy-lès-Lyon, , France
Institut de Cancérologie Paris Nord
Sarcelles, , France
CH Sens
Sens, , France
CH Broussais
St-Malo, , France
ICANS - Institut de cancérologie Strasbourg Europe
Strasbourg, , France
Hôpital Foch
Suresnes, , France
CHR Metz-Thionville / Hôpital de Mercy
Thionville, , France
Hôpitaux du Léman
Thonon-les-Bains, , France
Hôpital d'Instruction des Armées Saint-Anne
Toulon, , France
Clinique Pasteur - Groupe Oncorad Garonne
Toulouse, , France
Clinique Pasteur - Oncosud
Toulouse, , France
Institut Claudius Regaud
Toulouse, , France
CHU Bretonneau
Tours, , France
Centre Hospitalier de Troyes
Troyes, , France
CH Jean Bernard
Valenciennes, , France
Clinique des Dentellières
Valenciennes, , France
Institut de Cancérologie de Lorraine (ICL) - Centre Alexis Vautrin
Vandœuvre-lès-Nancy, , France
Gustave Roussy
Villejuif, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A01190-57
Identifier Type: OTHER
Identifier Source: secondary_id
19.06.45
Identifier Type: OTHER
Identifier Source: secondary_id
GINECO-OV128
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.